1. The polypeptide GALNT6 Displays Redundant Functions upon Suppression of its Closest Homolog GALNT3 in Mediating Aberrant O-Glycosylation, Associated with Ovarian Cancer Progression
   Razan Sheta et al, 2019, International Journal of Molecular Sciences CrossRef
2. Renal antiporter ClC-5 regulates collagen I/IV through the β-catenin pathway and lysosomal degradation
   Mònica Durán et al, 2024, Life Science Alliance CrossRef
3. Colorectal cancer stem cell vaccine with high expression of MUC1 serves as a novel prophylactic vaccine for colorectal cancer
   Mei Guo et al, 2020, International Immunopharmacology CrossRef
4. MUC1: Structure, Function, and Clinic Application in Epithelial Cancers
   Wenqing Chen et al, 2021, International Journal of Molecular Sciences CrossRef
5. Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer
   Mukulika Bose et al, 2023, Translational Research CrossRef
6. MUC1-EGFR crosstalk with IL-6 by activating NF-κB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma
   Hongyu Xu et al, 2024, Annals of Medicine CrossRef
7. The Role of MUC1 in Renal Cell Carcinoma
   Martina Milella et al, 2024, Biomolecules CrossRef
8. The surface dominant antigen MUC1 is required for colorectal cancer stem cell vaccine to exert anti-tumor efficacy
   Mei Guo et al, 2020, Biomedicine & Pharmacotherapy CrossRef
9. MUC16 impacts tumor proliferation and migration through cytoplasmic translocation of P120-catenin in epithelial ovarian cancer cells: an original research
   Xin Chen et al, 2019, BMC Cancer CrossRef
10. MUC1: An emerging target in cancer treatment and diagnosis
    Liangliang Qing et al, 2022, Bulletin du Cancer CrossRef